The bill amends section 317K of the Public Health Service Act to revise membership and data authorities for State maternal mortality review committees, require the CDC to publish and disseminate annual best-practice guidance for preventing maternal deaths, and reauthorize and increase federal funding for the program. It inserts explicit language to include obstetricians and gynecologists among clinical specialties, clarifies how committees may use data sources, and directs coordination with death certifiers to improve death record quality, including amending cause-of-death information when appropriate.
This matters for public-health officials, hospitals, perinatal quality collaboratives, and vital-records offices because the bill pairs a sizable funding increase with new expectations about data sharing and annual guidance. The statutory changes expand the operational tools available to review committees while raising practical questions about state-level authority over death certificates, the mechanics of changing cause-of-death information, and how federally issued best practices will be adopted at the hospital and collaborative level.
At a Glance
What It Does
The bill amends 42 U.S.C. 247b–12 to (1) add specific clinical representation for maternal mortality review committees, (2) permit and direct coordination with death certifiers to improve death-record quality and allow amendment of cause-of-death entries, (3) require the CDC—consulting with HRSA—to issue and disseminate best-practice guidance at least annually, and (4) reauthorize the program at $100 million per year for FY2026–2030.
Who It Affects
Directly affected parties include State maternal mortality review committees, hospitals and perinatal quality collaboratives that will receive CDC guidance, State professional society groups, CDC and HRSA program offices, and death certifiers (medical examiners and coroners) who will be asked to coordinate and, in some cases, amend death certificates.
Why It Matters
The bill couples technical changes that strengthen review committees’ access to and use of mortality data with an expanded federal investment. That combination can improve case review quality and prevention guidance, but it also raises operational and legal questions about how death-certificate amendments and cross-jurisdictional data practices will work in practice.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill makes three types of changes to the federal maternal mortality review framework. First, it tweaks committee composition and data-use language inside section 317K(d).
By explicitly naming obstetricians and gynecologists among clinical specialties, it narrows any ambiguity about who should sit on review panels. It also softens a mandate to obtain certain data by replacing the phrase “as applicable” with “if available,” which signals reliance on existing data availability while not creating a new federal subpoena power.
Second, the bill strengthens review committees’ ability to get usable death-certificate information. It adds an explicit requirement that committees coordinate with death certifiers—medical examiners and coroners—to improve the collection and quality of death records and authorizes amending cause-of-death information on death certificates as appropriate.
That change is operational: it anticipates active follow-up between review committees and vital-records offices to correct or clarify death-cause data used in reviews.Third, the bill creates an annual dissemination duty for the CDC (in consultation with HRSA) to compile and distribute best practices for preventing maternal mortality and morbidity. The recipients named in the statute are hospitals, State professional society groups, and perinatal quality collaboratives.
Finally, the bill reauthorizes funding at a higher level—$100 million per year for fiscal years 2026 through 2030—replacing the previous $58 million authorization for prior years. Together, the statutory edits expand federal support and outline how federal agencies should push prevention practices into clinical and quality-improvement settings.
The Five Things You Need to Know
The bill amends 42 U.S.C. 247b–12(d)(1)(A) to add “including obstetricians and gynecologists” to the list of clinical specialties for maternal mortality review committees.
It changes language in 317K(d)(3)(A)(i) to require use of certain data “if available,” reducing a prior “as applicable” construct and effectively deferring to data availability when compiling case information.
The statute now directs review committees to coordinate with death certifiers and explicitly permits amending cause-of-death information on death certificates to improve record quality.
Section 317K(e) (newly inserted) requires the CDC, consulting with HRSA, to disseminate best practices on maternal mortality prevention to hospitals, State professional societies, and perinatal quality collaboratives at least once per fiscal year.
The bill increases the program authorization to $100,000,000 for each of fiscal years 2026 through 2030 (replacing the prior $58,000,000 authorization for earlier years).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Clarify committee membership to include OB‑GYNs
This amendment inserts “including obstetricians and gynecologists” into the clause describing clinical specialties for State maternal mortality review committees. Practically, the change reduces ambiguity during committee formation: states and funding recipients must ensure OB‑GYN representation is considered part of the clinical mix. That matters for case review perspectives and for clinical recommendations that flow from the committees’ findings.
Data-use language: 'if available' replaces 'as applicable'
Replacing “as applicable” with “if available” narrows the statutory posture: review committees should use listed data sources when those sources exist, but the federal text stops short of creating an obligation to obtain unavailable records. For program managers, this creates a practical standard tied to data access realities rather than a backstop to compel production, which shifts attention to building access agreements and technical capacity at the state level.
Coordination with death certifiers and authority to amend death certificates
The amendment adds an explicit duty to coordinate with death certifiers to improve death-record collection and quality and mentions amending cause‑of‑death information as appropriate. This gives review committees a clearer statutory path to request corrections or clarifications from medical examiners/coroners. Implementation will depend on state vital-records procedures—but the statute now anticipates active engagement and corrective action when case review identifies errors.
Annual CDC best-practices dissemination to hospitals and collaboratives
This new subsection requires the CDC, consulting with HRSA, to compile and disseminate best practices on preventing maternal mortality and morbidity at least once per fiscal year to hospitals, State professional society groups, and perinatal quality collaboratives. The provision names recipients and sets an annual cadence, shifting the program from passive support to a regular federal conduit for clinical and quality-improvement guidance.
Funding increase and multi‑year reauthorization
The bill redesignates existing subsections and replaces the previous authorization amount with $100 million per year for FY2026–2030. The uptick is significant: it expands the federal investment in review committees and related activities, but the text does not specify how funds must be apportioned among grants, technical assistance, or data infrastructure—leaving allocation details to implementing guidance or appropriation language.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State maternal mortality review committees — receive clearer statutory authority to include OB‑GYNs, coordinate with death certifiers, and request corrections to death records, improving the accuracy and clinical relevance of reviews.
- Hospitals and perinatal quality collaboratives — become regular recipients of CDC-issued best-practice guidance, which can inform protocols, drills, and quality-improvement initiatives focused on maternal health.
- Pregnant and postpartum patients (especially those whose deaths are likely to be preventable) — benefit indirectly when improved review data and annual guidance translate into targeted prevention measures and system-level changes.
- State professional medical societies — gain a statutory channel for receiving and implementing federal best practices, increasing their role in disseminating standards to clinicians and hospitals.
- CDC and HRSA program offices — obtain explicit statutory responsibility to coordinate and an expanded authorization to fund technical assistance, surveillance, and dissemination activities.
Who Bears the Cost
- HHS (CDC and HRSA) — the agencies must develop, publish, and disseminate annual best practices and administer a larger program; that creates staffing and coordination costs not fully detailed in the statutory text.
- State vital‑records offices, coroners, and medical examiners — will face additional requests to coordinate with review committees and sometimes to amend cause‑of‑death entries, which consumes staff time and may require procedural changes.
- Hospitals and perinatal collaboratives — expected to receive and implement guidance, which can require training, new protocols, data collection changes, or investment in quality‑improvement capacity.
- States administering review committees — must ensure committee composition and data access align with the statute, potentially requiring logistical or legal work to change bylaws or data‑sharing agreements.
- Federal appropriators and taxpayers — the authorization increases federal spending by a substantial margin; appropriation decisions will determine whether the full authorized amount is provided.
Key Issues
The Core Tension
The central tension is between improving maternal mortality surveillance and prevention through stronger federal coordination and preserving the practical, legal, and institutional autonomy of state vital‑records systems and local providers; the bill empowers review committees and federal agencies to push for better data and guidance, but real-world gains depend on state law, coroner/medical examiner practices, and hospitals’ capacity to adopt recommendations.
Two implementation bottlenecks are obvious. First, the statutory push to coordinate with death certifiers and amend cause‑of‑death information bumps into a fragmented state landscape: states set procedures for death‑certificate corrections and coroners’ independence varies widely.
The bill authorizes coordination but does not change state vital‑records law, so practical effect depends on each state’s willingness and legal framework for post‑mortem record changes. That could produce uneven improvements in data quality across states.
Second, the bill requires the CDC to disseminate best practices annually but leaves adoption and enforcement to downstream actors. The statute names hospitals, State professional societies, and perinatal collaboratives as recipients but does not attach implementation timelines, performance measures, or funding restrictions tied to adoption.
Increased authorization provides resources, but without specific earmarks for implementation assistance, uptake in under-resourced hospitals could lag, limiting the prevention benefits the statute intends to produce.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.